TG Therapeutics reported 903K in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
TG Therapeutics TGTX:US 903K 486K
Abbvie ABBV:US $ 10733M 756M
Amgen AMGN:US $ 5077M 182M
Ardelyx ARDX:US $ 4.39M 3.89M
Arrowhead Research ARWR:US $ 1.32M 1.17M
Bayer BAYN:GR 17.82B 4.54B
Biogen BIIB:US $ 2021.4M 59.7M
Corcept Therapeutics CORT:US $ 27.18M 0.45M
Curis CRIS:US $ 2.06M 1.16M
Dynavax Technologies DVAX:US $ 136.94M 5.12M
Gilead Sciences GILD:US $ 3787M 706M
Intercept Pharmaceuticals ICPT:US $ 46.14M 1.47M
Johnson & Johnson JNJ:US $ 15594M 311M
Karyopharm Therapeutics KPTI:US $ 24.99M 2.5M
Novartis NOVN:VX 8.68B 395M
Novavax NVAX:US $ 478.16M 23.16M
Ptc Therapeutics PTCT:US $ 141.29M 30.83M
Puma Biotechnology PBYI:US $ 27.04M 5.49M
Regeneron Pharmaceuticals REGN:US $ 4839M 1197.5M
Spectrum Pharmaceuticals SPPI:US $ 0.64M 0.39M
Verastem VSTM:US $ 2.64M 2.13M
Vertex Pharmaceuticals VRTX:US $ 1292.8M 156M
Ziopharm Oncology ZIOP:US $ 0 1.11M